Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now renders a 403 Forbidden error with accompanying header text, and the visible study content appears unavailable while the site header/footer remain; this indicates the study record is currently inaccessible.SummaryDifference21%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedResults were posted on 2026-08-28 with the study marked as Completed. The update adds result sections for ORR, DOR, PFS, and irPFS, and provides links to the Study Protocol and Statistical Analysis Plan, along with the Results First Posted timeline.SummaryDifference2%

- Check48 days agoChange DetectedThe page now shows the full Study Details for NCT03457948, including enrollment and study dates, sponsor and collaborators, and locations. It also adds detailed Study Record Dates metadata (First Submitted, First Posted, Last Update, Study Record Updates) to document the record history.SummaryDifference60%

- Check55 days agoChange DetectedThe page's revision metadata was updated from v3.6.4 to v3.6.5, indicating an incremental version update.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a deployment of updates to the study details page. This reflects a newer build of the page rather than a modification to the study data itself.SummaryDifference0.1%

- Check76 days agoChange DetectedThe study page now shows 'Results Submitted' instead of 'No Results Posted', indicating that results are in the submission process or awaiting posting.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.